Uncategorized
ThromboGenics reports financial update, Jetrea progression
ThromboGenics reported a decrease in cash and investments in the first quarter 2015 compared with the fourth quarter 2014, according to a press release.Cash and investments totaled €121.4 million compared with €127.1 million in the previous quarter.